新型β-肾上腺素能受体拮抗剂SL 75212口服和静脉给药后的血药浓度及药效学效应[会议论文] - Suppr | 超能文献

Blood concentrations and pharmacodynamic effects of SL 75212, a new beta-adrenoceptor antagonist, after oral and intravenous administration [proceedings].

作者信息

Bianchetti G, Gomeni R, Kilborn J R, Morselli P L, Taylor E A, Warrington S J

出版信息

Br J Clin Pharmacol. 1979 Oct;8(4):403P-404P.

PMID:41556

Abstract

摘要

相似文献

1

Blood concentrations and pharmacodynamic effects of SL 75212, a new beta-adrenoceptor antagonist, after oral and intravenous administration [proceedings].新型β-肾上腺素能受体拮抗剂SL 75212口服和静脉给药后的血药浓度及药效学效应[会议论文]

Br J Clin Pharmacol. 1979 Oct;8(4):403P-404P.

2

Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration.新型β-肾上腺素能受体拮抗剂倍他洛尔（SL 75212）口服和静脉给药后的血药浓度及药效学效应

Br J Clin Pharmacol. 1980 Nov;10(5):449-52. doi: 10.1111/j.1365-2125.1980.tb01787.x.

3

Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocker SL 75212 in healthy volunteers [proceedings].新型β-肾上腺素能受体阻滞剂SL 75212单次口服剂量对健康志愿者的心血管效应[会议论文集]

Br J Clin Pharmacol. 1979 Oct;8(4):403P.

4

Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.新型β-肾上腺素能受体阻滞剂倍他洛尔（SL 75212）多次口服给药后在人体的药代动力学

Arzneimittelforschung. 1980;30(11):1912-6.

5

[The effect of a short-term oral administration of trimepranol on plasma renin activity (author's transl)].短期口服三甲丙咪嗪对血浆肾素活性的影响（作者译）

Sb Lek. 1975 Apr;77(4):102-6.

6

[Clinical investigation of o-(2-hydroxy-3-(tert.-butylamino)-propoxy)-benzonitrile under glucose load by means of continuous recording].[通过连续记录对葡萄糖负荷下的邻-(2-羟基-3-(叔丁基氨基)-丙氧基)-苯甲腈进行临床研究]

Arzneimittelforschung. 1974 Sep;24(9):1328-30.

7

Serum thromboxane B2 after intravenous administration of talinolol and propranolol in healthy subjects.健康受试者静脉注射他林洛尔和普萘洛尔后的血清血栓素B2

Pharmazie. 1991 Jan;46(1):58-9.

8

[The effect of bolus esmolol on the cardiocirculatory response to endotracheal intubation].[单次静脉注射艾司洛尔对气管插管时心脏循环反应的影响]

Ann Fr Anesth Reanim. 1989;8 Suppl:R96.

9

Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist [proceedings].新型强效心脏选择性β-肾上腺素能受体拮抗剂SL 75212的初步研究[会议论文集]

Br J Pharmacol. 1979 Jul;66(3):445P.

10

[Pharmacoclinical study of oral butofilolol in arterial hypertension. Effects on heart rate, blood pressure and the renin-angiotensin system].口服布托洛尔治疗动脉高血压的药物临床研究。对心率、血压及肾素-血管紧张素系统的影响

Therapie. 1983 May-Jun;38(3):265-9.

引用本文的文献

1

Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.倍他洛尔（SL 75212）在人体中的β-肾上腺素能受体阻断作用及药代动力学

Br J Clin Pharmacol. 1980 Jul;10(1):41-9. doi: 10.1111/j.1365-2125.1980.tb00500.x.

2

Betaxolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension.倍他洛尔。对其药效学、药代动力学特性及在高血压治疗中的疗效的综述。

Drugs. 1986 Jan;31(1):6-28. doi: 10.2165/00003495-198631010-00002.

3

Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension.眼部用倍他洛尔。对其药理特性以及在青光眼和高眼压症中的治疗效果的综述。

Drugs. 1990 Jul;40(1):75-90. doi: 10.2165/00003495-199040010-00005.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。